64 results on '"Mohamed K. Kamel"'
Search Results
2. National Trends and Perioperative Outcomes of Robotic-assisted Hepatectomy in the USA: A Propensity-score Matched Analysis from the National Cancer Database
- Author
-
Charles A. Keane, Faiz Tuma, Mohamed K. Kamel, and John Blebea
- Subjects
medicine.medical_specialty ,Database ,business.industry ,Mortality rate ,medicine.medical_treatment ,Perioperative ,Total Hepatectomy ,computer.software_genre ,Cardiac surgery ,Cardiothoracic surgery ,Propensity score matching ,medicine ,Surgery ,Hepatectomy ,business ,computer ,Abdominal surgery - Abstract
A paucity of data exists on the national use of robotic hepatectomy. We assessed national trends and perioperative outcomes of robotic hepatectomy in the USA. In addition, factors associated with use of the robotic approach were analyzed. The National Cancer Database (NCDB) was queried for patients undergoing hepatectomy from 2010 to 2016. Patients undergoing total hepatectomy for transplant were excluded. Factors associated with the use of the robotic approach were assessed using logistic regression multivariable analysis. Propensity-score analysis was performed (robotic vs. laparoscopic and robotic vs. open approaches), and perioperative outcomes were compared between the matched groups. The robotic approach was used in 287 patients (110 hospitals). Utilization of the robotic approach increased significantly on the national level from 0.8% in 2010 to 4.1% in 2016 (P
- Published
- 2021
3. Alternative surgical training approaches during COVID-19 pandemic
- Author
-
Mohamed K. Kamel, Maher Ghanem, Faiz Tuma, John Blebea, and Saad Shebrain
- Subjects
Value (ethics) ,Medical education ,Coping (psychology) ,Reflection (computer programming) ,Restructuring ,business.industry ,Distancing ,education ,Educational technology ,Review Article ,General Medicine ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Health care ,ComputingMilieux_COMPUTERSANDEDUCATION ,Medicine ,030211 gastroenterology & hepatology ,Surgery ,business ,Curriculum - Abstract
Importance Coping with the COIVD-19 global-pandemic major changes in healthcare and educational operational policies, mandates the implementation of alternative surgical curriculum objects (components) to replace some of the traditional face-to-face activities. Objective The objective of the study is to review and discuss various alternative curriculum objects (components) that can be used to restructure conventional surgical training curricula during the Declared Healthcare Emergency surgery rotations. The goal is to identify and recommend effective alternative educational activities that are compliant with the new social physical distancing regulations. Evidence review Various curricular components and objects were examined. The educational value of the curriculum objects is studied and analyzed in terms of feasibility, knowledge gain/learning effectiveness, the need for facilitation or feedback, and the evaluation. Several curriculum objects were proposed with description of their value and applications. Findings The selected and proposed activities include scenario-based MCQ writing exercises, video-based surgical skills interactive training, online learning modules, virtual rounding, reflection assignments, surgical skills simulation training, research education, and medical education learning. Their educational value is described and scaled. Conclusion There is urgent and challenging need for surgical training using additional alternative curriculum objects (components). Working with the available resources and experiences is crucial to maximize the learning outcomes. Distance (online) education and educational technology tools and concepts provide a spectrum of valuable educational activities. Further work and studies are needed to optimize their utility., Highlights • The COIVD-19 pandemic has imposed major changes in healthcare and educational operational policies. • This review discusses alternative curriculum objects that can be used to restructure traditional surgical training curricula. • Effective alternative educational activities that are compliant with the social distancing regulations were discussed.
- Published
- 2021
4. Valve-sparing root replacement in patients with bicuspid aortopathy: An analysis of cusp repair strategy and valve durability
- Author
-
Natalia S. Ivascu, Christopher Lau, Mohamed K. Kamel, Mohamed Rahouma, Matthew Wingo, Leonard N. Girardi, Erin Iannacone, and Mario Gaudino
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Aortic aneurysm ,0302 clinical medicine ,Bicuspid aortic valve ,Bicuspid Aortic Valve Disease ,stomatognathic system ,Bicuspid valve ,medicine.artery ,medicine ,Humans ,In patient ,cardiovascular diseases ,Heart Valve Prosthesis Implantation ,Aorta ,business.industry ,Mean age ,Middle Aged ,medicine.disease ,Surgery ,Treatment Outcome ,030228 respiratory system ,Aortic Valve ,cardiovascular system ,Mitral Valve ,Cusp (anatomy) ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Valve-sparing root replacement using reimplantation techniques is increasingly applied to bicuspid aortopathy. Long-term durability of cusp repair is unclear. We analyze midterm results using a conservative approach to cusp repair.From 2006 to 2018, 327 patients underwent valve-sparing reimplantation, 66 with bicuspid valves. Leaflets were analyzed after reimplantation. A majority (51/66) required no cusp repair. Fifteen patients had cusp repair limited to closure of unfused raphe or central plication. Patients were followed by echocardiography.Mean age of patients was 44.7 ± 12.3 years. The cusp repair group had a higher incidence of preoperative moderate (10% vs 40%) or severe (4% vs 33.3%) aortic insufficiency (P .001). There was no operative mortality or major complication. Mean follow-up was 51.6 ± 40.8 months. On postoperative echocardiography, incidence of none, trace, or mild aortic insufficiency was 41.3% (19/46), 43.5% (20/46), and 15.2% (7/46) in the no cusp repair group and 40% (6/15), 40% (6/15), and 20% (3/15) in the cusp repair group, respectively (P = .907). Few patients progressed in degree of aortic insufficiency. No patients required reoperation. At 5 years, freedom from any aortic insufficiency was 46.9% versus 15.8% (P = .013), and freedom from greater than trace aortic insufficiency was 59.1% versus 36.9% (P = .002) due to the higher rate of postoperative trace and mild aortic insufficiency with cusp repair. There was no difference in freedom from greater than mild aortic insufficiency (92.1% vs 100%; P = .33).Valve-sparing root replacement is reliably performed with bicuspid aortic valves whether or not cusp reconstruction is necessary. Few patients progress to greater than mild aortic insufficiency. Need for reoperation is rare in midterm follow-up.
- Published
- 2021
5. Staple Line Thickening After Sublobar Resection: Reaction or Recurrence?
- Author
-
Brendon M. Stiles, Brian Sun, Sebron Harrison, Mohamed K. Kamel, Jeffrey L. Port, Nasser K. Altorki, Abu Nasar, and Benjamin Lee
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Lung Neoplasms ,Radiography ,Hilum (biology) ,030204 cardiovascular system & hematology ,Malignancy ,03 medical and health sciences ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Surgical Stapling ,Parenchyma ,medicine ,Carcinoma ,Humans ,Pneumonectomy ,Lung ,Parenchymal Tissue ,Aged ,Retrospective Studies ,business.industry ,Granulation tissue ,Soft tissue ,Retrospective cohort study ,medicine.disease ,medicine.anatomical_structure ,030228 respiratory system ,Female ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Nuclear medicine - Abstract
Background Stapling across lung parenchyma may lead to tissue granulation, which could be confused radiographically with recurrence. We sought to define the time course and radiographic characteristics of such thickening and to determine their association with recurrence. Methods Patients who underwent limited resection for non-small cell lung cancer were included. Surveillance computed tomography scans were reviewed to characterize the morphology and size of staple line granulation tissue. Radiological and clinical findings were analyzed and univariate predictors of recurrence were examined. Results We characterized 78 patients for tissue granulation a total of 314 times in serial scans. On initial postoperative scans, 3.8% (n = 3) of staple lines showed no thickening and 17.9% (n = 14) showed thickening less than 2 mm, whereas 78.2% (n = 61) showed thickening 2 mm or greater. Of the 75 staple lines with thickening, soft tissue was characterized as linear in 32.0% (n = 24), focal along the pleura, hilum, or parenchyma in 24.0% (n = 18), and nodular in 44.0% (n = 33). Subsequent scans revealed that 25.3% of these areas (n = 19) did not change in shape or size over time, 58.7% (n = 44) showed regressive changes, and 16.0% (n = 12) showed progressive changes, the thickening of which in all 12 of these patients showed an increase in the largest dimension by 2 mm or greater. Among the 78 patients, 7.7% (n = 6) had biopsy-proven recurrence along the staple line. An increase in the largest dimension by 2 mm or greater (83.3% versus 9.7%; P = .001) and radiologic concern for malignancy (66.7% versus 11.1%; P = .001) predicted staple line recurrence. Conclusions Staple line thickening is a frequent occurrence after pulmonary limited resection, but rarely indicative of recurrence. The characteristics and initial size of granulation tissue do not predict recurrence. Increases in tissue 2 mm or greater at the staple line over time predict local recurrence, which typically occurs after a prolonged time interval.
- Published
- 2020
6. Sternal Reconstruction Using Customized 3D-Printed Titanium Implants
- Author
-
Mohamed K. Kamel, Bruna Vaughan, Ann Cheng, Brendon M. Stiles, Jason A. Spector, Nasser K. Altorki, and Jeffrey L. Port
- Subjects
Pulmonary and Respiratory Medicine ,3d printed ,Rib cage ,Sternum ,business.industry ,Anterior chest wall ,chemistry.chemical_element ,Anatomy ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,chemistry ,Prosthesis design ,Medicine ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Titanium - Abstract
In this report, we describe the use of custom-designed 3D-printed titanium implants to reconstruct the anterior chest wall, including the sternum and adjacent ribs, in two patients. These cases are the first to be reported in the United States, and they are among a handful performed around the world.
- Published
- 2020
7. Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity Matched Analysis of the National Cancer Database
- Author
-
Brendon M. Stiles, Benjamin Lee, Mohamed K. Kamel, J. Port, Sebron Harrison, and Nasser K. Altorki
- Subjects
Database ,business.industry ,medicine.medical_treatment ,Hazard ratio ,Cancer ,Esophageal cancer ,medicine.disease ,computer.software_genre ,Confidence interval ,Esophagectomy ,Propensity score matching ,Medicine ,Surgery ,Lymph ,Stage (cooking) ,business ,computer - Abstract
MINI In patients with esophageal cancer who received neoadjuvant chemoradiation, the total number of resected nodes is a significant determinant of improved survival regardless of clinical nodal status. OBJECTIVES The aim of this study was to explore the potential value of extended nodal-dissection following neoadjuvant chemoradiation (CRT), by analyzing data from the National Cancer Database (NCDB). BACKGROUND A CROSS-trial post-hoc analysis showed that the number of dissected lymph nodes was associated with improved survival in patients undergoing upfront surgery but not in those treated with neoadjuvant CRT. METHODS The NCDB was queried (2004-2014) for patients who underwent esophagectomy following induction CRT. Predictors of overall survival (OS) were assessed. The optimal number of dissected LNs associated with highest survival benefit was determined by multiple regression analyses and receiver-operating characteristic curve analysis. The whole cohort was divided into 2 groups based on the predefined cutoff number. The two groups were propensity-matched (PMs). RESULTS Esophagectomy following induction-CRT was performed in 14,503 patients. The number of resected nodes was associated with improved OS in the multivariable analysis (hazard ratio for every 10 nodes: 0.95 (95% confidence interval: 0.93-0.98). The cutoff number of resected LNs that was associated with the highest survival benefit was 20 nodes. In the PM groups, patients in the "≥20 LNs" group had a 14% relative-increase in OS (P = 0.002), despite having more advanced pathological stages (stage II-IV: 76% vs 72%, P < 0.001), and higher number of positive nodes (0-2 vs 0-1, P < 0.001). CONCLUSIONS The total number of resected nodes is a significant determinant of improved survival following induction CRT in patients with either node negative or node positive disease. In the matched groups, patients with higher number of resected lymph nodes had higher OS rate, despite having more advanced pathological disease and higher number of resected positive lymph nodes.
- Published
- 2021
8. Cardiotoxicity with immune system targeting drugs: a meta-analysis of anti-PD/PD-L1 immunotherapy randomized clinical trials
- Author
-
Maha Yahia, Mohamed K. Kamel, Fabrizio D'Ascenzo, Adham Elmously, Ayah A Hassan, Nagla Abdel Karim, Ahmed Abouarab, Ola Gaber, Mario Gaudino, Massimo Baudo, Leonard N. Girardi, Mohamed Rahouma, Ihab Saad, Mona Kamal, John C. Morris, M. Rahouma, Abdelrahman Mohamed, Ihab Eldessouki, Katherine D. Gray, and Galal Ghaly
- Subjects
Male ,0301 basic medicine ,Oncology ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,Immunology ,B7-H1 Antigen ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Lung cancer ,Melanoma ,Randomized Controlled Trials as Topic ,Chemotherapy ,Cardiotoxicity ,business.industry ,Incidence (epidemiology) ,Cancer ,Immunotherapy ,medicine.disease ,030104 developmental biology ,030220 oncology & carcinogenesis ,Meta-analysis ,Female ,business - Abstract
Background: With antiprogrammed death receptor-1 (anti-PD-L1) therapy, a recent meta-analysis reported higher incidence of cutaneous, endocrine and gastrointestinal complications especially with dual anti-PD-L1 immunotherapy (IMM). Methods: Our primary outcome was assessment of all cardiotoxicity grades in IMM compared with different treatments, thus a systemic review and a meta-analysis on randomized clinical trials (RCTs) were done. Results: We included 11 RCTs with 6574 patients (3234 patients in IMM arm vs 3340 patients in the other arm). Three non-small-cell lung cancer RCTs, seven melanoma RCTs and only one prostatic cancer RCT met the inclusion criteria. There were five RCTs that compared monoimmunotherapy to chemotherapy “(n = 2631 patients)”. No difference exists in all cardiotoxicity grades or high-grade cardiotoxicity (p > 0.05). Lung cancer exhibited a higher response rate and lower mortality in IMM. Conclusion: There was no reported statistically significant cardiotoxicity associated with anti-PD/PD-L1 use. Lung cancer subgroups showed better response and survival rates.
- Published
- 2019
9. National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches†
- Author
-
J. Port, Sebron Harrison, Mohamed Rahouma, Nasser K. Altorki, Mohamed K. Kamel, Benjamin Lee, Abdelrahman M. Abdelrahman, Brendon M. Stiles, and Jonathan Villena-Vargas
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Robotic Surgical Procedures ,Humans ,Medicine ,Propensity Score ,Thymic carcinoma ,Aged ,Retrospective Studies ,Thoracic Surgery, Video-Assisted ,business.industry ,Mortality rate ,Induction chemotherapy ,Thymus Neoplasms ,General Medicine ,Odds ratio ,Perioperative ,Middle Aged ,Thymectomy ,medicine.disease ,United States ,Confidence interval ,Surgery ,Treatment Outcome ,030220 oncology & carcinogenesis ,Video-assisted thoracoscopic surgery ,Propensity score matching ,Female ,Cardiology and Cardiovascular Medicine ,business ,human activities - Abstract
OBJECTIVES: Despite the recent increased rate of adoption of robotic approaches for the resection of thymic tumours, their use is still limited to large-volume academic centres. To date, a large-scale analysis of the robotic approach has not been performed. We assessed the recent trends and outcomes of robotic thymectomies in the United States compared to those of open and video-assisted thoracoscopic surgical (VATS) approaches. METHODS: The National Cancer Database was queried for patients who underwent resection for thymic tumours (2010–2014). Predictors of using the robotic approach were estimated by logistic regression analysis. Propensity matching analysis (robotic versus open and robotic versus VATS) was done (1:1—caliper 0.05), controlling for age, gender, comorbidity index, induction treatment, tumour size and tumour extension. RESULTS: A total of 2558 thymectomies were performed (robotic = 300, VATS = 280, open = 1978). The use of a robotic approach increased from 6% (2010) to 14% (2014). The number of hospitals performing at least 1 robotic thymectomy increased from 22 (2010) to 52 (2014). Independent predictors influencing the choice of a robotic approach included an academic research/integrated cancer programme [odds ratio (OR) 1.66, confidence interval (CI) 1.22–2.27], later year of diagnosis (2014; OR 2.23, CI 1.31–3.80) and a patient’s race (Asian) (OR 1.68, CI 1.05–2.69). A robotic approach was less likely to be utilized in midwestern hospitals (OR 0.65, CI 0.42–0.99), in larger tumours (cm) (OR 0.85, CI 0.80–0.90), with invasion of adjacent organs (OR 0.55, CI 0.37–0.82), thymic carcinoma (OR 0.62, CI 0.40–0.97) and following induction chemotherapy (OR 0.22, CI 0.08–0.61). In a propensity-matched analysis, there were no differences in the incidence of positive margins, nodal dissection, 30-day readmission rates and 30-/90-day mortality rates between the groups. However, a robotic approach was associated with fewer conversions compared to VATS, with a trend towards a shorter length of stay compared to an open approach. There were no differences in the 5-year overall survival rate between the matched groups (robotic 93% vs VATS 94%; P = 0.571; robotic 91% vs open 80%; P = 0.094). CONCLUSIONS: Over a 4-year study period, there was a significant increase in robotic utilization for thymectomies and an increase in the number of hospitals performing the procedure. In a matched analysis, a robotic approach was comparable to a VATS or an open approach. Current trends demonstrate increased robotic utilization for small thymomas with excellent perioperative results.
- Published
- 2019
10. Sensitivity and specificity of fine needle aspiration for the diagnosis of mediastinal lesions
- Author
-
Tamara Giorgadze, Mohamed K. Kamel, Jeffrey L. Port, Alan Marcus, Nasser K. Altorki, Navneet Narula, Brendon M. Stiles, Andre L. Moreira, and June Koizumi
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Pathology ,Thymoma ,Adolescent ,Biopsy, Fine-Needle ,Mediastinal Neoplasms ,Sensitivity and Specificity ,Pathology and Forensic Medicine ,Metastatic carcinoma ,Surgical pathology ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Paraganglioma ,Biopsy ,medicine ,Humans ,Child ,Thymic carcinoma ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Mediastinum ,General Medicine ,Middle Aged ,Thoracic Surgical Procedures ,medicine.disease ,body regions ,030104 developmental biology ,medicine.anatomical_structure ,Fine-needle aspiration ,030220 oncology & carcinogenesis ,Female ,Radiology ,Triage ,business - Abstract
Fine needle aspiration cytology (FNAC) of mediastinal masses allows for rapid on-site evaluation and the triaging of material for ancillary studies. However, surgical pathology is often considered to be the gold standard for diagnosis. This study examines the sensitivity and specificity of FNAC compared to a concurrent or subsequent surgical pathology specimen in 77 mediastinal lesions. The overall sensitivity for mediastinal mass FNAC was 78% and the overall specificity was 98%. For individual categories the sensitivity and specificity of FNAC was respectively as follows: inflammatory/infectious (33%, 99%), metastatic carcinoma (93%, 100%), lymphoma (84%, 97%), cysts (25%, 100%), soft tissue tumors (100%, 100%), paraganglioma (50%, 100%), germ cell tumor (100%, 99%), thymoma (87%, 94%), thymic carcinoma (60%, 100%), benign thymus (0%, 100%), and indeterminate (100%, 90%). For different locations within the mediastinum the sensitivity and specificity of FNAC was respectively as follows: anterosuperior mediastinum (80%, 98%), posterior mediastinum (33%, 95%), middle mediastinum (100%, 100%), and mediastinum, NOS (79%, 99%). Thus, mediastinal FNAC is fairly sensitive, very specific, and is a valuable technique in the diagnosis of mediastinal masses.
- Published
- 2019
11. Do individual surgeon volumes affect outcomes in thoracic surgery?†
- Author
-
Art Sedrakyan, Mohamed K. Kamel, Corbin Cleary, Brendon M. Stiles, Tiany Sun, Sebron Harrison, and Nasser K. Altorki
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Hospitals, Low-Volume ,Thoracic Surgical Procedure ,medicine.medical_treatment ,Patient characteristics ,030204 cardiovascular system & hematology ,Resection ,03 medical and health sciences ,Pneumonectomy ,0302 clinical medicine ,medicine ,Humans ,Hospital Mortality ,Surgeon volume ,Aged ,Retrospective Studies ,Surgeons ,business.industry ,General surgery ,General Medicine ,Middle Aged ,medicine.disease ,Comorbidity ,Treatment Outcome ,Cardiothoracic surgery ,030220 oncology & carcinogenesis ,Female ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Medicaid ,Hospitals, High-Volume - Abstract
OBJECTIVES: Minimum volume standards for thoracic surgical procedures have been advocated to improve outcomes. However, such standards are controversial within the thoracic surgery literature, and the methodology to determine cut points between high- and low-volume hospitals has been criticized. Furthermore, while multiple studies have examined hospital volume and its relationship with outcomes, there have been very few attempts to study this issue from the perspective of the individual thoracic surgeon. The aim of this study was to determine if surgeon volume is associated with differences in outcomes using a large state-wide database. METHODS: The study utilized the New York State Department of Health Statewide Planning and Research Cooperative (SPARCS) data for analysis. Patients who underwent major lung resections including sublobar resection, lobectomy and pneumonectomy from 1995 to 2014 were included and were categorized into 3 subgroups based on the extent of resection. Patient characteristics included age, gender, race, insurance and comorbidities. Surgeon information was obtained by using a unique identifier. Average annual surgical volumes of sublobar resection, lobectomy and pneumonectomy were calculated separately and grouped into 3 categories based on the tertiles. Demographic data and comorbidities were compared between the various volume groups to analyse the resulting complications. Primary outcomes were in-hospital mortality and 30-day readmission. RESULTS: There were a total of 99 576 major lung resections performed between 1995 and 2014 in the SPARCS database. Among these, the majority were wedge or segmental resections (n = 54 953, 55.2%) followed by lobectomy (n = 40 421, 40.6%) and pneumonectomy (n = 4202, 4.2%). In-hospital mortality was significantly greater for low-volume surgeons compared to high-volume surgeons for all resection groups. Additionally, low-volume surgeons had higher 30-day readmission rates for patients undergoing lobectomy and pneumonectomy. However, low-volume surgeons as a group were more likely to operate on black patients and patients with Medicaid, and black race was an independent predictor of mortality across all resection groups. The vast majority of surgeons performing lobectomy (89.5%) were in the low-volume group. CONCLUSIONS: Low-volume surgeons had higher rates of in-hospital mortality compared to their high-volume counterparts. However, the vast majority of surgeons performing lobectomy (89.5%) were in the low-volume group, and low-volume surgeons operated on higher percentages of black patients. These findings suggest that minimal volume standards would significantly impact the current delivery of thoracic surgery in the US.
- Published
- 2019
12. Sublobar resection is comparable to lobectomy for screen-detected lung cancer
- Author
-
Mohamed K. Kamel, Jeffrey L. Port, Benjamin Lee, Sebron Harrison, Nasser K. Altorki, and Brendon M. Stiles
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,Carcinoma, Non-Small-Cell Lung ,medicine ,Humans ,Prospective Studies ,Lung cancer ,Pneumonectomy ,Neoplasm Staging ,Retrospective Studies ,Lung ,business.industry ,Hazard ratio ,Perioperative ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Treatment Outcome ,Video-assisted thoracoscopic surgery ,Cohort ,National Lung Screening Trial ,Female ,Cardiology and Cardiovascular Medicine ,business ,Wedge resection (lung) - Abstract
Sublobar resection is frequently offered to patients with small, peripheral lung cancers, despite the lack of outcome data from ongoing randomized clinical trials. Sublobar resection may be a particularly attractive surgical strategy for screen-detected lung cancers, which have been suggested to be less biologically aggressive than cancers detected by other means. Using prospective data collected from patients undergoing surgery in the National Lung Screening Trial, we sought to determine whether extent of resection affected survival for patients with screen-detected lung cancer.The National Lung Screening Trial database was queried for patients who underwent surgical resection for confirmed lung cancer. Propensity score matching analysis (lobectomy vs sublobar resection) was done (nearest neighbor, 1:1, matching with no replacement, caliper 0.2). Demographics, clinicopathologic and perioperative outcomes, and long-term survival were compared in the entire cohort and in the propensity-matched groups. Multivariable logistic regression analysis was done to identify factors associated with increased postoperative morbidity or mortality.We identified 1029 patients who underwent resection for lung cancer in the National Lung Screening Trial, including 821 patients (80%) who had lobectomy and 166 patients (16%) who had sublobar resection, predominantly wedge resection (n = 114, 69% of sublobar resection). Patients who underwent sublobar resection were more likely to be female (53% vs 41%, P = .004) and had smaller tumors (1.5 cm vs 2 cm, P .001). The sublobar resection group had fewer postoperative complications (22% vs 32%, P = .010) and fewer cardiac complications (4% vs 9%, P = .033). For stage I patients undergoing sublobar resection, there was no difference in 5-year overall survival (77% for both groups, P = .89) or cancer-specific survival (83% for both groups, P = .96) compared with patients undergoing lobectomy. On multivariable logistic regression analysis, sublobar resection was the only factor associated with lower postoperative morbidity/mortality (odds ratio, 0.63; 95% confidence interval, 0.40-0.98). To compare surgical strategies in balanced patient populations, we propensity matched 127 patients from each group undergoing sublobar resection and lobectomy. There were no differences in demographics or clinical and tumor characteristics among matched groups. There was again no difference in 5-year overall survival (71% vs 65%, P = .40) or cancer-specific survival (75% vs 73%, P = .89) for patients undergoing lobectomy and sublobar resection, respectively.For patients with screen-detected lung cancer, sublobar resection confers survival similar to lobectomy. By decreasing perioperative complications and potentially preserving lung function, sublobar resection may provide distinct advantages in a screened patient cohort.
- Published
- 2021
13. Commentary: Do radiological findings play a role in the screening of COVID-19 in patients undergoing cardiac surgery?
- Author
-
Mohamed K. Kamel
- Subjects
Pulmonary and Respiratory Medicine ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,COVID-19 ,General Medicine ,Cardiac surgery ,Internal medicine ,Radiological weapon ,Medicine ,Humans ,Mass Screening ,In patient ,Surgery ,Cardiac Surgical Procedures ,business ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,ADULT – Commentary - Abstract
Due to the outbreak of Severe Acute Respiratory Syndrome coronavirus (SARS-Cov-2), an efficient COVID-19 screening strategy is required for patients undergoing cardiac surgery. The objective of this prospective observational study was to evaluate the role of preoperative computed tomography (CT) screening for COVID-19 in a population of COVID-19 asymptomatic patients scheduled for cardiac surgery. Between the 29th of March and the 26th of May 2020, patients asymptomatic for COVID-19 underwent a CT-scan the day before surgery, with reverse-transcriptase polymerase-chain reaction (RT-PCR) reserved for abnormal scan results. The primary endpoint was the prevalence of abnormal scans, which was evaluated using the CO-RADS score, a COVID-19 specific grading system. In a secondary analysis, the rate of abnormal scans was compared between the screening cohort and matched historical controls who underwent routine preoperative CT-screening prior to the SARS-Cov-2 outbreak. Of the 109 patients that underwent CT-screening, an abnormal scan result was observed in 7.3% (95% confidence interval: 3.2-14.0%). One patient, with a normal screening CT, was tested positive for COVID-19, with the first positive RT-PCR on the ninth day after surgery. A rate of preoperative CT-scan abnormalities of 8% (n = 8) was found in the unexposed historical controls (P0.999). In asymptomatic patients undergoing cardiac surgery, preoperative screening for COVID-19 using computed tomography will identify pulmonary abnormalities in a small percentage of patients that do not seem to have COVID-19. Depending on the prevalence of COVID-19, this results in an unfavorable positive predictive value of CT screening. Care should be taken when considering CT as a screening tool prior to cardiac surgery.
- Published
- 2021
- Full Text
- View/download PDF
14. Students and faculty perception of distance medical education outcomes in resource-constrained system during COVID-19 pandemic. A cross-sectional study
- Author
-
Mohamed K. Kamel, Aussama K. Nassar, Lisa M. Knowlton, Naseer Kadhim Jawad, and Faiz Tuma
- Subjects
Medical education ,business.product_category ,Teaching method ,Distance education ,Student engagement ,03 medical and health sciences ,0302 clinical medicine ,Internet access ,ComputingMilieux_COMPUTERSANDEDUCATION ,Medicine ,Active listening ,Curriculum ,business.industry ,Virtual meeting ,COVID-19 ,General Medicine ,Online learning ,030220 oncology & carcinogenesis ,Virtual learning environment ,030211 gastroenterology & hepatology ,Surgery ,The Internet ,Cross-sectional Study ,business - Abstract
Introduction The COVID-19 pandemic has imposed significant challenges on medical education worldwide, particularly in experience- and resource-limited regions of the world. Collaborative efforts of educators and academic institutions are necessary to facilitate the adaptation to the new educational reality. In this study, challenges and outcomes of a newly implemented distance education curriculum are examined to share findings and provide recommendations. Methods An alternative distance education curriculum with online resources and virtual lectures was developed and implemented in February 2020 at the Wasit University College of Medicine in Iraq. A post-implementation survey was developed for both faculty instructors and students to evaluate the program's effectiveness and perception. Results were compared between both groups. The study was approved by the University's Dean and exempted by the research committee for anonymity. Results A total of 636 students and 81 instructors were surveyed. Approximately 33% of students and 51% of instructors found online education equivalent or superior to traditional face-to-face teaching methods. Almost 69% of students and 51% of instructors reported increased difficulties with virtual learning, primarily due to challenges with the available technology, unreliable internet connectivity, as well as perceive fatigue when listening to online lectures. Conclusions Distance education provides a worthwhile alternative during the COVID-19 pandemic, including in regions of limited experience. Adequate preparation, good quality audio-visuals and Internet, and student engagement activities are recommended to improve the quality of education., Highlights • Distance education is relatively new to medical education in resource-limited countries. • This survey evaluated the feasibility of distance education and the education's perceived quality. • Students found that online learning was difficult and required moderate technical skills. • Instructors found the effort and time for preparation were acceptable. • Distance education should be integrated into the standard medical education curriculum.
- Published
- 2020
15. Teaching Operative Surgery to Medical Students Using Live Streaming During COVID-19 Pandemic
- Author
-
Tuma Faiz, Steve Vance, Mohamed K. Kamel, and Omar Marar
- Subjects
2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,COVID-19 ,Operative surgery ,medicine.disease ,Live streaming ,Education, Distance ,Surgical Procedures, Operative ,Pandemic ,medicine ,Humans ,Surgery ,Medical emergency ,business ,Webcasts as Topic - Published
- 2020
16. National trends and perioperative outcomes of robotic oesophagectomy following induction chemoradiation therapy: a National Cancer Database propensity-matched analysis
- Author
-
Jeffrey L. Port, Sebron Harrison, Mohamed Rahouma, Nasser K. Altorki, Brendon M. Stiles, Adam N Sholi, Mohamed K. Kamel, and Benjamin Lee
- Subjects
Pulmonary and Respiratory Medicine ,Database ,business.industry ,medicine.medical_treatment ,General Medicine ,Perioperative ,030204 cardiovascular system & hematology ,Esophageal cancer ,medicine.disease ,computer.software_genre ,Log-rank test ,03 medical and health sciences ,0302 clinical medicine ,Esophagectomy ,030220 oncology & carcinogenesis ,Propensity score matching ,medicine ,Surgery ,Robotic surgery ,Stage (cooking) ,Cardiology and Cardiovascular Medicine ,business ,computer ,Neoadjuvant therapy - Abstract
OBJECTIVES Oesophagectomy following induction chemoradiation therapy (CRT) is technically challenging. To date, little data exist to describe the feasibility of a robotic approach in this setting. In this study, we assessed national trends and outcomes of robotic oesophagectomy following induction CRT compared to the traditional open approach. METHODS The National Cancer Database was queried for patients who underwent oesophagectomy following induction CRT (2010–2014). Trends of robotic utilization were assessed by a Mantel–Haenszel test of trend. Propensity matching controlled for differences in age, gender, comorbidity, stage, histology and tumour location between the robotic and open groups. Overall survival was estimated by Kaplan–Meier analysis and compared by a log-rank test RESULTS Oesophagectomy following induction CRT was performed in 6958 patients. Of them, 555 patients (8%) underwent robotic surgery (5% converted to an open approach). Between 2010 and 2014, utilization of a robotic approach increased from 3% to 11% (Mantel–Haenszel, P CONCLUSIONS Robotic oesophagectomy after induction CRT is feasible and associated with shorter hospitalization compared to an open approach, and does not compromise the adequacy of oncological resection, perioperative outcomes or long-term survival.
- Published
- 2020
17. Overestimation of Screening Related Complications in the National Lung Screening Trial
- Author
-
Brendon M. Stiles, Mohamed K. Kamel, S. Kariyawasam, and Nasser K. Altorki
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Medicine ,National Lung Screening Trial ,business - Published
- 2020
18. Robotic versus Laparoscopic Cholecystectomy: Case-Control Outcome Analysis and Surgical Resident Training Implications
- Author
-
John Blebea, Nico Conti, Mohamed K. Kamel, Maher Ghanem, Majd Zayout, Faiz Tuma, Samuel Shaheen, and Ghaith Qudah
- Subjects
robotic ,medicine.medical_specialty ,business.industry ,General surgery ,Resident training ,medicine.medical_treatment ,General Engineering ,Outcome analysis ,Emergency department ,cholecystectomy ,030204 cardiovascular system & hematology ,laparoscopic ,clinical outcomes ,03 medical and health sciences ,0302 clinical medicine ,Surgical ergonomics ,General Surgery ,Propensity score matching ,medicine ,Cholecystectomy ,business ,Body mass index ,Laparoscopic cholecystectomy ,030217 neurology & neurosurgery ,surgical training - Abstract
Background The robotic approach in surgery is becoming more widely used in many subspecialties. Robot-assisted laparoscopic procedures provide potential improvements in clinical outcomes due to improved visualization and enhanced surgical ergonomics. In this study, we measured and compared outcomes of robot-assisted laparoscopic cholecystectomy with the conventional laparoscopic technique, as well as the implications for the training of surgical residents. Method We compared a total of 244 patients undergoing minimally invasive cholecystectomies performed by one surgeon between July 2013 and June 2016 examining relevant clinical outcomes including operative room (OR) time, length of hospital stay (LOS), readmission to the hospital, post-operative emergency department (ED) visits, and post-operative pain between laparoscopic single-incision cholecystectomy and robot-assisted laparoscopic cholecystectomy. A chi-square test and Student's t-test were used to compare these variables between the two groups. Propensity score matching (PSM) was used using gender, age, and body mass index (BMI) as variables. Results From the total number of procedures of 244, 144 were included in the laparoscopic group and 100 in the robot-assisted group. The robot-assisted patients had a shorter post-operative LOS (mean: 0.8 vs. 1.6 days; p = 0.002). There was no significant difference in the OR time (mean: 64.8 vs. 65.0 minutes; p = 0.945), readmissions (4.0% vs. 3.5%; p = 0.830), post-operative ED visits (7.0% vs. 7.6%; p = 0.851), or post-operative pain (13.0% vs. 21.3%; p= 0.137). Robotic cholecystectomy patients were younger (mean: 46 vs. 52 years; p = 0.023) and had lower BMIs (mean: 31 vs. 33; p = 0.038). Because of these differences, we compared the two groups using PSM that confirmed the shorter LOS in the robotic group (mean: 0.9 vs. 1.9; p = 0.009). Conclusions These results demonstrate that robotic cholecystectomies can reduce LOS for patients undergoing laparoscopic cholecystectomy, without increasing OR time. Increased surgeon experience with robotic procedures and improved OR efficiency will allow greater opportunities for resident participation. Robotic training curricula need to be employed and objectively evaluated to improve surgical resident skill acquisition and provide earlier and progressive clinical participation in robotic procedures.
- Published
- 2020
19. Predictors of Survival After Treatment of Oligometastases After Esophagectomy
- Author
-
Jeffrey L. Port, Galal Ghaly, Nasser K. Altorki, Mohamed K. Kamel, Sebron Harrison, Abu Nasar, Mohamed Rahouma, and Brendon M. Stiles
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,Esophageal Neoplasms ,medicine.medical_treatment ,Recurrent Esophageal Carcinoma ,New York ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Gastroenterology ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Carcinoma ,Humans ,Medicine ,Neoplasm Metastasis ,Aged ,Neoplasm Staging ,Retrospective Studies ,business.industry ,Proportional hazards model ,Hazard ratio ,Retrospective cohort study ,Middle Aged ,Prognosis ,medicine.disease ,Confidence interval ,Esophagectomy ,Survival Rate ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Female ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,After treatment ,Follow-Up Studies - Abstract
Background Recurrent esophageal carcinoma (EC) has a dismal prognosis. However, prior studies showed that selected patients with isolated recurrence may benefit from definitive therapy. The aim of this study was to identify the predictors of postrecurrence survival (PRS) in patients with isolated EC recurrence who were treated with curative intent. Methods A retrospective review of a prospective database (1988 to 2015) was performed to identify all recurrent EC patients after curative esophagectomy. Demographic and clinicopathologic data were reviewed. The probability of PRS was estimated with the Kaplan-Meier method. Predictors of PRS after definitive therapy for isolated EC recurrence were determined by the multivariable Cox proportional hazards model. Results Of the 640 curative esophagectomies, 241 patients (37.7%) experienced recurrences (median follow-up 50 months). Fifty-six patients (9%) received definitive treatment of isolated EC recurrence (31 were treated surgically with or without chemotherapy-radiotherapy [CTRT] and 25 received definitive CTRT alone). Median time to recurrence (TTR) was 19 months. The 1- and 3-year PRSs were 78% and 38% (median survival 26 months). On multivariable analysis; TTR was the only significant independent predictor for survival after recurrence (hazards ratio 0.98, 95% confidence interval: 0.96 to 0.99, p = 0.034). No pronounced difference was found in disease-free survival or in PRS between recurrent patients treated with operation with or without CTRT and patients who received definitive CTRT. Conclusions A select subgroup of patients with isolated EC recurrence can be treated with curative intent. TTR was the best predictor for PRS.
- Published
- 2018
20. Options of Surgical Curriculum Structure and Objects During COVID-19 Pandemic
- Author
-
Tuma Faiz, Maher Ghanem, Mohamed K. Kamel, Saad Shebrain, and John Blebea
- Subjects
Medical education ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,COVID-19 ,Internship and Residency ,General Surgery ,Pandemic ,Humans ,Medicine ,Surgery ,Curriculum ,business ,Surgical curriculum - Published
- 2020
21. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer
- Author
-
Brendon M. Stiles, Mohamed K. Kamel, Abu Nasar, Paul C. Lee, Sebron Harrison, Jeffrey L. Port, Andrew B. Nguyen, Mohamed Rahouma, Nasser K. Altorki, and Galal Ghaly
- Subjects
Male ,Lung Neoplasms ,Databases, Factual ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Metastasis ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Cause of Death ,Positron Emission Tomography Computed Tomography ,Pneumonectomy ,Academic Medical Centers ,Incidence (epidemiology) ,Biopsy, Needle ,Middle Aged ,Prognosis ,Immunohistochemistry ,Primary tumor ,Peripheral ,030220 oncology & carcinogenesis ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,Wedge resection (lung) ,Adult ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Disease-Free Survival ,Statistics, Nonparametric ,03 medical and health sciences ,Fluorodeoxyglucose F18 ,Predictive Value of Tests ,medicine ,Humans ,Neoplasm Invasiveness ,Lung cancer ,Aged ,Neoplasm Staging ,Retrospective Studies ,Receiver operating characteristic ,business.industry ,medicine.disease ,Survival Analysis ,ROC Curve ,Lymph Node Excision ,Surgery ,Lymph Nodes ,Neoplasm Recurrence, Local ,NODAL ,business - Abstract
Background Despite the relatively high sensitivity of fluorodeoxyglucose-positron emission tomography (PET) and computed tomography (CT) scans used for staging of non-small cell lung cancer (NSCLC), a subset of patients with peripherally located clinical T1a N0 will be upstaged due to pathologic nodal disease. It is important to study this risk of upstaging, especially if local treatments, such as wedge resection or stereotactic body radiation therapy, are potential treatment modalities. Our aim was to determine the rate of pathologic N1/N2 disease in peripherally located clinical T1a N0 NSCLC and predictive factors for nodal metastasis. Methods A retrospective review of a prospective database (2000 to 2015) identified 1,342 patients with clinical T1a N0 NSCLC, and 914 (68%) underwent lobectomy. Among this group, 449 patients had peripherally located tumors and were deemed node negative by fluorodeoxyglucose-PET/CT scan. The relationship between clinicopathologic features and the PET maximal-standardized uptake value (SUVmax) of the primary tumor was investigated. Predictors for nodal metastasis were determined by multivariable logistic regression analysis. The receiver operating characteristic curve was used to assess the cutoff value of PET-SUVmax on the incidence of nodal metastasis. Results Nodal metastasis was detected in 9.6% (43 of 449) of the patients: 4.5% (n = 20) had pN1 and 5.1% (n = 23) had pN2 metastasis. The relationship between SUVmax and development of pathologic nodal metastasis was calculated using the receiver operating characteristic curve with cutoff point at SUVmax of 3.3. In multivariable analysis, PET-SUVmax exceeding 3.3 was the only independent predictor for N1/N2 metastasis ( p = 0.016). Disease-free survival showed a trend of poor survival for patients with nodal metastasis ( p = 0.068). Conclusions High PET-SUVmax of the primary tumor is associated with elevated risk of nodal disease for peripheral T1a N0 NSCLC patients. Further diagnostic procedures, such as endobronchial ultrasound, may be required, especially if wedge resection or stereotactic body radiation therapy are being considered.
- Published
- 2017
22. Endoscopic versus open radial artery harvesting: A meta-analysis of randomized controlled and propensity matched studies
- Author
-
Lucas B. Ohmes, Fabio Barili, Christopher Lau, Umberto Benedetto, Mario Gaudino, Antonino Di Franco, Robert F. Tranbaugh, Mohamed K. Kamel, Leonard N. Girardi, and Mohamed Rahouma
- Subjects
coronary artery surgery ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Time Factors ,MEDLINE ,030204 cardiovascular system & hematology ,law.invention ,wound complication ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine.artery ,Surgical Wound Dehiscence ,medicine ,Clinical endpoint ,Humans ,Surgical Wound Infection ,Radial artery ,Propensity Score ,Randomized Controlled Trials as Topic ,radial artery harvesting ,business.industry ,Graft Survival ,Endoscopy ,Odds ratio ,Prognosis ,Databases, Bibliographic ,Confidence interval ,Surgery ,meta-analysis ,patency rate ,Systematic review ,030228 respiratory system ,Meta-analysis ,Radial Artery ,endoscopic radial artery harvesting ,Tissue and Organ Harvesting ,Cardiology and Cardiovascular Medicine ,business - Abstract
BackgroundWe sought to investigate the impact of radial artery harvesting techniques on clinical outcomes using a meta‐analytic approach limited to randomized controlled trials and propensity‐matched studies for clinical outcomes, in which graft patency was analyzed.MethodsA systematic literature review was conducted using PubMed and MEDLINE to identify publications containing comparisons between endoscopic radial artery harvesting (ERAH) and open harvesting (ORAH). Only randomized controlled trials and propensity‐matched series were included. Data were extracted and analyzed with RevMan. The primary endpoint was wound complication rate, while secondary endpoints were patency rate, early mortality, and long‐term cardiac mortality.ResultsSix studies comprising 743 patients were included in the meta‐analysis. Of them 324 (43.6%) underwent ERAH and 419 (56.4%) ORAH. ERAH was associated with a lower incidence of wound complications (odds ratio: 0.33, confidence interval 0.14‐0.77; p = 0.01). There were no differences in graft patency, and early and long‐term cardiac mortality between the two techniques.ConclusionERAH reduces wound complications and does not affect graft patency, or short‐ and long‐term mortality compared to ORAH.
- Published
- 2017
23. Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer
- Author
-
Abu Nasar, Andrew B. Nguyen, Paul C. Lee, Mohamed Rahouma, Jeffrey L. Port, Nasser K. Altorki, Brendon M. Stiles, Mohamed K. Kamel, and Galal Ghaly
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Multivariate analysis ,medicine.diagnostic_test ,business.industry ,Mediastinum ,Retrospective cohort study ,030204 cardiovascular system & hematology ,medicine.disease ,Surgery ,Mediastinoscopy ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Biopsy ,medicine ,Carcinoma ,Radiology ,Stage (cooking) ,Cardiology and Cardiovascular Medicine ,Lung cancer ,business - Abstract
Background Patients with persistent N2 disease after induction have poor survival. Many of these patients may have had mediastinoscopy before induction therapy, making reassessment of the mediastinum by repeat mediastinoscopy hazardous and inaccurate. The sensitivity and specificity of endobronchial ultrasonography and nodal fine-needle aspiration in this setting is unclear. In this study, we sought to identify the clinical predictors of persistent N2 disease after induction therapy, which may help in selecting the patients most likely to benefit from surgical resection. Methods A retrospective review of a prospective database (1990 to 2014) was performed to identify patients who had surgical resection after induction therapy for clinical stage IIIA-N2 non-small cell lung cancer. Multivariable logistic regression analysis was performed to determine independent predictors of persistent N2 disease. Results 203 patients (56% female; median age 64 years) underwent potentially curative lung resection after induction therapy. Ninety-seven patients (48%) had pathologic nodal downstaging (pN0/N1), which was associated with significantly better overall survival compared with patients with persistent N2 disease (5 years, 56% versus 35%, p = 0.047). Univariate and multivariate analysis showed that upper or middle lobe location and less than 60% reduction of N2 SUVmax were independent predictors of persistent N2 disease. Conclusions Patients with upper lobe tumors and less than 60% reduction in N2 SUVmax are more likely to have persistent N2 disease, which is often associated with poor survival rates. These clinical prognostic criteria may help surgeons in stratifying patients and properly selecting optimal surgical candidates.
- Published
- 2017
24. National Trends and Perioperataive Outcomes of Robotic-Assisted Hepatectomy in the US: A Propensity Score-Matched Analysis from the National Cancer Database
- Author
-
Mohamed K. Kamel and Faiz Tuma
- Subjects
medicine.medical_specialty ,business.industry ,Robotic assisted ,General surgery ,medicine.medical_treatment ,Propensity score matching ,medicine ,Cancer ,Surgery ,National trends ,Hepatectomy ,business ,medicine.disease - Published
- 2020
25. Commentary: Role of pre-emptive analgesia in reversing the opioid epidemic
- Author
-
Mohamed K. Kamel
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Opioid epidemic ,business.industry ,Pain ,Analgesics, Opioid ,Humans ,Medicine ,Surgery ,Reversing ,Analgesia ,Opioid Epidemic ,Cardiology and Cardiovascular Medicine ,business ,Intensive care medicine - Published
- 2020
26. Radial Artery Versus Right Internal Thoracic Artery Versus Saphenous Vein as the Second Conduit for Coronary Artery Bypass Surgery:A Network Meta-Analysis of Clinical Outcomes
- Author
-
Thomas A. Schwann, Christopher Lau, Cristiano Spadaccio, Jeremy R. Leonard, Mohamed K. Kamel, Umberto Benedetto, Giovanni J. Soletti, Mario Gaudino, Mohamed Rahouma, Gaelle Saint-Hilary, Derrick Y. Tam, Stephen E. Fremes, Antonino Di Franco, Ahmed Abouarab, Mario Iannaccone, Fabrizio D'Ascenzo, David P. Taggart, Roberto Lorusso, and Leonard N. Girardi
- Subjects
medicine.medical_specialty ,arterial conduits ,Bypass grafting ,MAMMARY ARTERY ,Network Meta-Analysis ,ANGIOGRAPHIC PREDICTORS ,PROPENSITY ,Internal thoracic artery ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Right internal thoracic artery ,Coronary artery bypass surgery ,coronary artery bypass graft surgery ,0302 clinical medicine ,Electrical conduit ,medicine.artery ,Internal medicine ,saphenous vein graft ,PATENCY ,medicine ,Humans ,Saphenous Vein ,030212 general & internal medicine ,Radial artery ,Coronary Artery Bypass ,Vein ,GRAFT-SURGERY ,Cardiovascular Surgery ,business.industry ,Systematic Review and Meta‐analysis ,Revascularization ,LONG-TERM SURVIVAL ,CONTEMPORARY CABG ,MYOCARDIAL REVASCULARIZATION ,coronary artery bypass ,medicine.anatomical_structure ,SINGLE ,PRACTICE GUIDELINES ,Radial Artery ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Artery - Abstract
Background There remains uncertainty regarding the second‐best conduit after the internal thoracic artery in coronary artery bypass grafting. Few studies directly compared the clinical results of the radial artery ( RA ), right internal thoracic artery ( RITA ), and saphenous vein ( SV ). No network meta‐analysis has compared these 3 strategies. Methods and Results MEDLINE and EMBASE were searched for adjusted observational studies and randomized controlled trials comparing the RA , SV , and/or RITA as the second conduit for coronary artery bypass grafting. The primary end point was all‐cause long‐term mortality. Secondary end points were operative mortality, perioperative stroke, perioperative myocardial infarction, and deep sternal wound infection ( DSWI ). Pairwise and network meta‐analyses were performed. A total of 149 902 patients (4 randomized, 31 observational studies) were included ( RA , 16 201, SV , 112 018, RITA, 21 683). At NMA , the use of SV was associated with higher long‐term mortality compared with the RA (incidence rate ratio, 1.23; 95% CI , 1.12–1.34) and RITA (incidence rate ratio, 1.26; 95% CI , 1.17–1.35). The risk of DSWI for SV was similar to RA but lower than RITA (odds ratio, 0.71; 95% CI , 0.55–0.91). There were no differences for any outcome between RITA and RA , although DSWI trended higher with RITA (odds ratio, 1.39; 95% CI , 0.92–2.1). The risk of DSWI in bilateral internal thoracic artery studies was higher when the skeletonization technique was not used. Conclusions The use of the RA or the RITA is associated with a similar and statistically significant long‐term clinical benefit compared with the SV . There are no differences in operative risk or complications between the 2 arterial conduits, but DSWI remains a concern with bilateral ITA when skeletonization is not used.
- Published
- 2019
27. High-dose versus low-dose opioid anesthesia in adult cardiac surgery: A meta-analysis
- Author
-
Mohamed Rahouma, Meghann M. Fitzgerald, Taylor L. Mustapich, Lisa Q. Rong, Kane O. Pryor, Antonino Di Franco, Ajita Naik, Mohamed K. Kamel, Michelle Demetres, Mario Gaudino, Ahmed Abouarab, and Kritika Mehta
- Subjects
Adult ,medicine.medical_specialty ,Remifentanil ,Anesthesia, General ,Fentanyl ,law.invention ,Sufentanil ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,030202 anesthesiology ,law ,medicine ,Humans ,030212 general & internal medicine ,Cardiac Surgical Procedures ,Stroke ,Randomized Controlled Trials as Topic ,Dose-Response Relationship, Drug ,business.industry ,Perioperative ,Length of Stay ,medicine.disease ,Intensive care unit ,Cardiac surgery ,Analgesics, Opioid ,Intensive Care Units ,Anesthesiology and Pain Medicine ,Anesthesia ,business ,medicine.drug - Abstract
Study Objective. We performed a systematic comparison of high-dose and low-dose opioid anesthesia in cardiac surgery. Design Systematic review and meta-analysis of randomized controlled trials (RCTs). Setting Operating room. Patients 1400 adult patients undergoing cardiac surgery using general anesthesia. Interventions All RCTs comparing the effects of various doses of intravenous opioids (morphine, fentanyl, sufentanil, and remifentanil) during adult cardiac surgery using general anesthesia published until May 2018 (full-text English articles reporting data from human subjects) were included. Measurements Primary outcome was intensive care unit (ICU) length of stay (LOS). Secondary outcomes were ventilation time, use of vasopressors, perioperative myocardial infarction, perioperative stroke, and hospital LOS. Main results Eighteen articles were included (1400 patients). There was no difference in ICU LOS between studies using high or low dose of opioids (both short-acting and long-acting) (standard mean difference [SMD]−0.02, 95%CI: −0.15–0.11, P = 0.74). Similarly, there was no difference in secondary outcomes of ventilation time (SMD−0.27, 95%CI: −0.63–0.09, P = 0.14), use of vasopressors (OR 0.61, 95%CI: 0.29–1.30, P = 0.20), myocardial infarction (risk difference 0.00, 95% CI: −0.02–0.03, P = 0.70), stroke (RD 0.00, 95% CI: −0.01–0.01, P = 0.92) and hospital LOS (SMD 0.03, 95% CI: −0.26–0.33, P = 0.84). At meta-regression, there was no effect of age, gender, or type of opioid on the difference between groups. Conclusions Our data suggest that low-dose opioids, both short acting and long acting, are safe and effective to use in adult cardiac surgery patients, independent of the clinical characteristics of the patients and the type of opioid used. In view of the current opioid epidemic, low-dose opioid anesthesia should be considered for cardiac surgery patients.
- Published
- 2019
28. Percutaneous coronary intervention versus coronary bypass surgery for unprotected left main disease: a meta-analysis of randomized controlled trials
- Author
-
Leonard N. Girardi, Mario Gaudino, Mohamed K. Kamel, Lucas B. Ohmes, Ahmed Abouarab, Jeremy R. Leonard, Christopher Lau, Mohamed Rahouma, and Antonino Di Franco
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Revascularization ,Rate ratio ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,cardiovascular diseases ,Myocardial infarction ,Stroke ,business.industry ,Percutaneous coronary intervention ,Odds ratio ,medicine.disease ,030220 oncology & carcinogenesis ,Conventional PCI ,Cardiology ,Surgery ,Systematic Review ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background: This meta-analysis of randomized controlled trials (RCTs) was aimed at comparing coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) for the treatment of unprotected left main coronary disease. Methods: All RCTs randomizing patients to any type of PCI with stents vs. CABG for left main disease (LMD) were included. Primary outcome was a composite of follow-up death/myocardial infarction/stroke/repeat revascularization. Secondary outcomes were peri-procedural mortality and the individual components of the primary outcome. Incidence rate ratio (IRR) or odds ratio (OR) and 95% confidence intervals (CIs) were pooled using a generic inverse variance method with random effects model. Subgroup analyses were done based on: (I) type of PCI [bare metal stents (BMS) vs. drug-eluting stents (DES)] and; (II) mean SYNTAX score tertiles. Leave one-out analysis and meta-regression were performed. Results: Six trials were included (4,700 patients; 2,349 PCI and 2,351 CABG). Follow-up ranged from 2.33 to 5 years. PCI was associated with higher risk of follow-up death/myocardial infarction/stroke/repeat revascularization (IRR =1.328, 95% CI, 1.114–1.582, P=0.002) and of repeated revascularization (IRR =1.754, 95% CI, 1.470–2.093, P
- Published
- 2018
29. Does a balanced transfusion ratio of plasma to packed red blood cells improve outcomes in both trauma and surgical patients? A meta-analysis of randomized controlled trials and observational studies
- Author
-
Andreas R. de Biasi, Umberto Benedetto, Diana Jodeh, Mario Gaudino, Mohamed K. Kamel, Christopher Lau, T. Sloane Guy, Leonard N. Girardi, Paul C. Lee, Mohamed Rahouma, Ahmed Abouarab, Lucas B. Ohmes, and Thomas M. Kelley
- Subjects
medicine.medical_specialty ,Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) rates ,030204 cardiovascular system & hematology ,Lung injury ,Global Health ,law.invention ,03 medical and health sciences ,Plasma ,24-h and 30-day/in-hospital mortality ,0302 clinical medicine ,Postoperative Complications ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Blood Transfusion ,Shock, Traumatic ,Hospital Mortality ,Intensive care medicine ,Randomized Controlled Trials as Topic ,business.industry ,packed red blood cell (RBC) ratio [Fresh frozen plasma (FFP)] ,030208 emergency & critical care medicine ,General Medicine ,Prognosis ,Survival Rate ,Red blood cell ,Observational Studies as Topic ,Meta-analysis ,medicine.anatomical_structure ,Cohort ,Surgery ,Observational study ,Fresh frozen plasma ,Packed red blood cells ,business ,Erythrocyte Transfusion - Abstract
Background: The effect of high transfusion ratios of fresh frozen plasma (FFP): packed red blood cell (RBC) on mortality is still controversial. Observational evidence contradicts a recent randomized controlled trial regarding mortality benefit. This is an updated meta-analysis, including a non-trauma cohort. Methods: Patients were grouped into high vs. low based on FFP:RBC ratio. Primary outcomes were 24-h and 30-day/in-hospital mortality. Secondary outcomes were acute respiratory distress syndrome and acute lung injury rates. Random model and leave-one-out-analyses were used. Results: In 36 studies, lower ratio showed poorer 24-h and 30-day survival (p < 0.001). In trauma and non-trauma settings, a lower ratio was associated with worse 24-h and 30-day mortality (P < 0.001). A ratio of 1:1.5 provided the largest 24-h and 30-day survival benefit (p < 0.001). The ratio was not associated with ARDS or ALI. Conclusions: High FFP:RBC ratio confers survival benefits in trauma and non-trauma settings, with the highest survival benefit at 1:1.5.
- Published
- 2018
30. Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis
- Author
-
Mohamed K. Kamel, Ahmed Abouarab, Eugene Shostak, Brendon M. Stiles, Jeffrey L. Port, John C. Morris, Ihab Eldessouki, Benjamin Lee, Abu Nasar, Mohamed Rahouma, Sebron Harrison, and Nasser K. Altorki
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Colorectal cancer ,Population ,Review ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Breast cancer ,Internal medicine ,Medicine ,030212 general & internal medicine ,Lung cancer ,education ,standardised mortality ratio (SMR) ,suicide ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,Cancer ,medicine.disease ,respiratory tract diseases ,SEER database ,lung cancer ,Standardized mortality ratio ,030220 oncology & carcinogenesis ,business ,psychological support - Abstract
Purpose Previous studies have reported that psychological and social distresses associated with a cancer diagnosis have led to an increase in suicides compared to the general population. We sought to explore lung cancer-associated suicide rates in a large national database compared to the general population, and to the three most prevalent non-skin cancers [breast, prostate and colorectal cancer (CRC)]. Methods The Surveillance, Epidemiology and End Results (SEER) database (1973–2013) was retrospectively reviewed to identify cancer-associated suicide deaths in all cancers combined, as well as for each of lung, prostate, breast or CRCs. Suicide incidence and standardised mortality ratio (SMR) were estimated using SEER*Stat-8.3.2 program. Suicidal trends over time and timing from cancer diagnosis to suicide were estimated for each cancer type. Results Among 3,640,229 cancer patients, 6,661 committed suicide. The cancer-associated suicide rate was 27.5/100,000 person years (SMR = 1.57). The highest suicide risk was observed in patients with lung cancer (SMR = 4.17) followed by CRC (SMR = 1.41), breast cancer (SMR = 1.40) and prostate cancer (SMR = 1.18). Median time to suicide was 7 months in lung cancer, 56 months in prostate cancer, 52 months in breast cancer and 37 months in CRC (p < 0.001). We noticed a decreasing trend in suicide SMR over time, which is most notable for lung cancer compared to the other three cancers. In lung cancer, suicide SMR was higher in elderly patients (70–75 years; SMR = 12), males (SMR = 8.8), Asians (SMR = 13.7), widowed patients (SMR = 11.6), undifferentiated tumours (SMR = 8.6), small-cell lung cancer (SMR = 11.2) or metastatic disease (SMR = 13.9) and in patients who refused surgery (SMR = 13). Conclusion The cancer-associated suicide rate is nearly twice that of the general population of the United States of America. The suicide risk is highest among the patients with lung cancer, particularly elderly, widowed, male patients and patients with unfavourable tumour characteristics. The identification of high-risk patients is of extreme importance to provide proper psychological assessment, support and counselling to reduce these rates.
- Published
- 2018
31. New-generation stents compared with coronary bypass surgery for unprotected left main disease:a word of caution
- Author
-
Mohamed Rahouma, Lucas B. Ohmes, Gianni D Angelini, Leonard N. Girardi, Miguel Sousa-Uva, Antonino Di Franco, David P. Taggart, Massimo Caputo, Giuseppe Biondi-Zoccai, Umberto Benedetto, Mario Gaudino, and Mohamed K. Kamel
- Subjects
Pulmonary and Respiratory Medicine ,Bare-metal stent ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Myocardial Infarction ,coronary artery bypass grafting ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Prosthesis Design ,Rate ratio ,Risk Assessment ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Humans ,Medicine ,030212 general & internal medicine ,Myocardial infarction ,Coronary Artery Bypass ,Randomized Controlled Trials as Topic ,coronary stenting ,business.industry ,Hazard ratio ,percutaneous coronary intervention ,Percutaneous coronary intervention ,Bayes Theorem ,medicine.disease ,left main disease ,Confidence interval ,Stroke ,Treatment Outcome ,surgical procedures, operative ,Bypass surgery ,Drug-eluting stent ,Centre for Surgical Research ,Cardiology ,Stents ,Surgery ,Diffusion of Innovation ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background With the advent of bare metal stents and drug-eluting stents, percutaneous coronary intervention has emerged as an alternative to coronary artery bypass grafting surgery for unprotected left main disease. However, whether the evolution of stents technology has translated into better results after percutaneous coronary intervention remains unclear. We aimed to compare coronary artery bypass grafting with stents of different generations for left main disease by performing a Bayesian network meta-analysis of available randomized controlled trials. Methods All randomized controlled trials with at least 1 arm randomized to percutaneous coronary intervention with stents or coronary artery bypass grafting for left main disease were included. Bare metal stents and drug-eluting stents of first- and second-generation were compared with coronary artery bypass grafting. Poisson methods and Bayesian framework were used to compute the head-to-head incidence rate ratio and 95% credible intervals. Primary end points were the composite of death/myocardial infarction/stroke and repeat revascularization. Results Nine randomized controlled trials were included in the final analysis. Six trials compared percutaneous coronary intervention with coronary artery bypass grafting (n = 4654), and 3 trials compared different types of stents (n = 1360). Follow-up ranged from 6 months to 5 years. Second-generation drug-eluting stents (incidence rate ratio, 1.3; 95% credible interval, 1.1-1.6), but not bare metal stents (incidence rate ratio, 0.63; 95% credible interval, 0.27-1.4), and first-generation drug-eluting stents (incidence rate ratio, 0.85; 95% credible interval, 0.65-1.1) were associated with a significantly increased risk of death/myocardial infarction/stroke when compared with coronary artery bypass grafting. When compared with coronary artery bypass grafting, the highest risk of repeat revascularization was observed for bare metal stents (hazard ratio, 5.1; 95% confidence interval, 2.1-14), whereas first-generation drug-eluting stents (incidence rate ratio, 1.8; 95% confidence interval, 1.4-2.4) and second-generation drug-eluting stents (incidence rate ratio, 1.8; 95% confidence interval, 1.4-2.4) were comparable. Conclusions The introduction of new-generation drug-eluting stents did not translate into better outcomes for percutaneous coronary intervention when compared with coronary artery bypass grafting.
- Published
- 2018
32. Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas
- Author
-
Sebron Harrison, Benjamin Lee, Brendon M. Stiles, Nasser K. Altorki, Mohamed Rahouma, Jeffrey L. Port, and Mohamed K. Kamel
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Time Factors ,New York ,Standardized uptake value ,Adenocarcinoma of Lung ,030204 cardiovascular system & hematology ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Positron Emission Tomography Computed Tomography ,medicine ,Humans ,Stage (cooking) ,Pneumonectomy ,Lymph node ,Aged ,Neoplasm Staging ,Retrospective Studies ,Lung ,business.industry ,Retrospective cohort study ,medicine.disease ,Survival Rate ,Dissection ,medicine.anatomical_structure ,Treatment Outcome ,030228 respiratory system ,Propensity score matching ,Adenocarcinoma ,Surgery ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Recent studies have suggested that lobectomy and segmentectomy hold equivalent oncologic outcomes, particularly for small, peripheral, subsolid nodules. However, for hypermetabolic nodules that are frequently associated with high rates of nodal disease, recurrence, or mortality, the optimum oncologic procedure was not assessed. We hypothesize that for hypermetabolic, cT1 N0 adenocarcinoma, lobectomy and segmentectomy are associated with comparable outcomes.A prospectively collected database was queried for patients with clinical stage IA lung adenocarcinoma who underwent lobectomy or segmentectomy (2000 to 2016) for hypermetabolic tumors (maximum standard uptake value [SUVmax] ≥ 3g/dL). To obtain balanced groups of patients, a propensity matching analysis was done.A total of 414 patients had hypermetabolic tumors and underwent lobectomy or segmentectomy. Patients were propensity matched (4:1) (lobectomy: n = 156, segmentectomy: n = 46). Patients in the lobectomy group had a higher rate of pathologic nodal upstaging (17% versus 7%, p = 0.085) and a higher pathologic upstaging rate (38% versus 26%, p = 0.143) than the segmentectomy group. In addition, the lobectomy group had a higher number of resected lymph nodes than the segmentectomy group (median lymph nodes resected: 14 versus 7, p0.001). No differences were found in in 5-year recurrence-free survival (RFS; 72% versus 69%, p = 0.679) or in 5-year cancer-specific survival (CSS; 92% versus 83%, p = 0.557) between patients who underwent lobectomy or segmentectomy, respectively.Our data show that lobectomy and segmentectomy are comparable oncologic procedures for patients with carefully staged cT1 N0 lung adenocarcinoma with hypermetabolic tumors (SUVmax ≥ 3g/dL). Although lobectomy was associated with a more thorough lymph node dissection, this did not translate into a higher rate of RFS or CSS compared with segmentectomy.
- Published
- 2018
33. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology
- Author
-
Mohamed K. Kamel, Jeffrey L. Port, Brendon M. Stiles, Benjamin Lee, Nasser K. Altorki, Sebron Harrison, Abu Nasar, and Mohamed Rahouma
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Time Factors ,Esophageal Neoplasms ,medicine.medical_treatment ,New York ,030204 cardiovascular system & hematology ,Disease-Free Survival ,Endoscopy, Gastrointestinal ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Positron Emission Tomography Computed Tomography ,medicine ,Humans ,Postoperative Period ,Prospective Studies ,Stage (cooking) ,Neoadjuvant therapy ,Aged ,Neoplasm Staging ,business.industry ,Proportional hazards model ,Esophageal cancer ,Middle Aged ,medicine.disease ,Prognosis ,Neoadjuvant Therapy ,Squamous carcinoma ,Esophagectomy ,Survival Rate ,Regimen ,030228 respiratory system ,Preoperative Period ,Disease Progression ,Adenocarcinoma ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Controversy exists over the optimal neoadjuvant therapy in patients with locally advanced esophageal cancer (EC). Although most groups favor neoadjuvant chemoradiation (nCRT), some prefer preoperative chemotherapy (nCT) without radiation. The objective of this study was to compare outcomes in EC patients undergoing either regimen, followed by surgery.We reviewed a prospectively collected database of EC patients undergoing esophagectomy after nCT or nCRT from 1989 to 2016. Choice of therapy was at the discretion of the multidisciplinary team. Disease-free survival (DFS) and cancer-specific survival (CSS) were compared by the Kaplan-Meier log-rank test. Independent predictors of CSS were estimated by Cox regression analysis.Among 700 EC patients 338 patients were treated with nCRT (n = 112) or nCT (n = 226) followed by surgery. Patients were well matched for age, gender, and clinical stage, although patients with squamous cell carcinoma were more likely to receive nCRT (49% vs 26%, p0.001). At surgery 90% and 91% of nCRT and nCT patients, respectively, underwent transthoracic esophagectomy. nCRT, in comparison with nCT, was associated with similar rates of Calvien-Dindo grade III/IV complications (34% vs 33%, p = 0.423) but with a trend toward higher perioperative mortality (5% vs 1%, p = 0.064). Among adenocarcinoma patients (n = 239) the use of nCRT was associated with higher rates of complete clinical response (18% vs 7.4%), pathologically negative lymph nodes (52% vs 30%, p = 0.001), and complete pathologic response (21% vs 5.1%, p0.001). However, there was no difference between nCRT and nCT for 5-year DFS (28% vs 31%, p = 0.636) or CSS (51% vs 52%, p = 0.824) among adenocarcinoma patients. For patients with squamous cell carcinoma (n = 98), nCRT and nCT had similar rates of complete clinical response (31% vs 26%, p = 0.205), but the rates of negative nodes (65% vs 46%, p = 0.064) and of complete pathologic response (42% vs 12%, p0.05) were higher with nCRT. For these patients nCRT was associated with no statistical difference in 5-year DFS (57% vs 40%, p = 0.595) but with improved 5-year CSS (87% vs 68%, p = 0.019) compared with nCT. On multivariable analysis for CSS, nCRT predicted improved survival for patients with squamous cell carcinoma (hazard ratio, 0.242; 95% confidence interval, 0.071-0.830) but not for those with adenocarcinoma (univariate hazard ratio, 0.940; 95% confidence interval, 0.544-1.623).For adenocarcinoma patients undergoing surgery for EC, nCRT leads to increased local tumor response compared with nCT alone but with no difference in survival. For squamous carcinoma patients nCRT appears to improve CSS compared with nCT. For patients with locally advanced EC targeted neoadjuvant regimens should be used depending on tumor histology.
- Published
- 2018
34. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases
- Author
-
Jeffrey L. Port, Brendon M. Stiles, Peter J. Kneuertz, Mohamed K. Kamel, Benjamin Lee, Mohamed Rahouma, Nasser K. Altorki, and Sebron Harrison
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,Carcinoid tumors ,Carcinoid Tumor ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,Pneumonectomy ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Humans ,Lymph node ,Aged ,Neoplasm Staging ,Retrospective Studies ,business.industry ,Incidence (epidemiology) ,Cancer ,Histology ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Prognosis ,United States ,Survival Rate ,Dissection ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,Surgery ,Female ,Lymph Nodes ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Pulmonary carcinoid tumors are often considered indolent tumors. The prognostic significance of lymph node (LN) metastases and the need for mediastinal dissection is controversial. We sought to determine the incidence, risk factors, and prognosis of LN metastases in resected carcinoid patients. Methods Patients undergoing lung resection for carcinoid and removal of ≥10 LNs were identified in the National Cancer Database from 2004 to 2014. Typical (TCs) and atypical carcinoids (ACs) were included. Clinical and pathologic LN status was assessed. Overall survival (OS) was analyzed using log-rank test and Cox hazard regression analysis. Results A total of 3,335 patients (TC 2,893; AC 442), underwent resection (lobectomy/bilobectomy 84%, pneumonectomy 8%, sublobar resection 8%). LN involvement was present in 21% of patients (N1 15%, N2 6%) and increased with tumor size and AC histology. Tumor size was an independent predictor of LN disease. The rate of nodal upstaging was 13% (TC 11%, AC 24%). Independent predictors of OS were AC type (HR 3.25 [95% CI 2.19-4.78]) and LN metastases (HR 2.3 [1.49-3.58]). LN disease was associated with worse survival for TC > 2 cm (5-year OS 87% versus 94%, p = 0.005) and AC (58% versus 88%, p = 0.001), but not for small (≤ 2 cm) TC patients (5-year OS 93% versus 92%, p = 0.67). Conclusions A substantial number of well-staged carcinoid patients had LN metastases. Large tumor size is a valuable predictor of carcinoid nodal disease. LN involvement was an independent predictor of worse survival. Nodal dissection in tumors > 2 cm and in atypical subtype can yield important prognostic information.
- Published
- 2018
35. Are racial differences in hospital mortality after coronary artery bypass graft surgery real? A risk-adjusted meta-analysis
- Author
-
Mario Gaudino, Gianni D Angelini, Mohamed K. Kamel, Massimo Caputo, Leonard N. Girardi, Umberto Benedetto, and Faiza M. Khan
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,coronary artery bypass grafting ,Ethnic group ,030204 cardiovascular system & hematology ,outcomes ,White People ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Medicine ,Humans ,Hospital Mortality ,Coronary Artery Bypass ,Healthcare Disparities ,Aged ,Asian ,business.industry ,Mortality rate ,Racial Groups ,Odds ratio ,Hispanic or Latino ,Middle Aged ,Random effects model ,mortality ,Confidence interval ,meta-analysis ,Black or African American ,medicine.anatomical_structure ,030228 respiratory system ,Centre for Surgical Research ,Meta-analysis ,Relative risk ,ethnicity ,Surgery ,Female ,Cardiology and Cardiovascular Medicine ,business ,Artery - Abstract
BackgroundDespite several reports, there are still conflicting data on the influence of ethnicity on mortality rates associated with coronary artery bypass grafting (CABG). We aimed to get further insights into the effect of race on mortality following CABG by performing a risk adjusted meta-analysis.MethodsRelevant studies were searched on PubMed, Embase, BioMed Central, and the Cochrane Central register. Pairwise meta-analysis was used to estimate the relative risk of hospital death of black, Hispanic, and Asian patients using white patients as reference. Risk adjusted meta-analytic estimates were obtained using generic inverse variance methods with random effect model.ResultsA total of 28 studies were selected for analysis. A total of 21 studies reported on hospital mortality in black (n = 222,892) versus white (n = 3,884,043) patients, 7 studies reported on Hispanic (n = 91,256) versus white (n = 1,458,524) and 9 studies reported on Asian (n = 27,820) versus white (n = 1,081,642). When compared with white patients, adjusted risk of hospital death was significantly greater for black patients (adjusted odds ratio [OR], 1.25; 95% confidence interval [CI], 1.13-1.39; P < .001), and not statistically different for Asian (OR, 1.33; 95% CI, 0.99-1.77; P = .05) and Hispanic patients (adjusted OR, 1.08; 95% CI, 0.94-1.23; P = .26). Meta-regression showed a significant trend toward lower mortality rates in most recent series in both black (P = .02) and white (P = .0007) and Asian (P = .01) but not for Hispanic (P = .41). However, as mortality rates were lower across the different races, the relative disadvantage between the study groups persisted, which may explain the lack of interaction between study period and race effect on mortality for black (adjusted P = .09), Asian (adjusted P = .63), and Hispanic (adjusted P = .97) patients.ConclusionsThe present meta-analysis showed that despite progress is being made in lowering in-hospital mortality rates among the major racial/ethnic groups, ethnical disparities in hospital mortality after CABG remain.
- Published
- 2017
36. Cerebrospinal-fluid drain-related complications in patients undergoing open and endovascular repairs of thoracic and thoraco-abdominal aortic pathologies: a systematic review and meta-analysis
- Author
-
Rob White, Mohamed K. Kamel, Mohamed Rahouma, Adam D. Lichtman, Leonard N. Girardi, Lisa Q. Rong, Kane O. Pryor, and Mario Gaudino
- Subjects
medicine.medical_specialty ,complications ,thoracic ,Aorta, Thoracic ,030204 cardiovascular system & hematology ,CSF drainage ,03 medical and health sciences ,Aortic aneurysm ,0302 clinical medicine ,Cerebrospinal fluid ,Postoperative Complications ,Epidemiology ,thoraco-abdominal ,Medicine ,Humans ,030212 general & internal medicine ,Settore MED/23 - CHIRURGIA CARDIACA ,aortic aneurysm ,Anesthesiology and Pain Medicine ,Aortic Aneurysm, Thoracic ,business.industry ,Incidence (epidemiology) ,Endovascular Procedures ,Csf drainage ,medicine.disease ,Confidence interval ,Surgery ,Treatment Outcome ,Meta-analysis ,Drainage ,business ,Complication - Abstract
Background Cerebrospinal-fluid (CSF) drainage is recommended by current guidelines for spinal protection during open and endovascular repairs of thoracic and thoraco-abdominal aortic aneurysms. In the published literature, great variability exists in the rate of CSF-related complications and morbidity. Herein, we perform a systematic review and meta-analysis on the incidence of CSF drainage-related complications, and compare the complication rates between open and endovascular repairs. Methods The systematic review was conducted according to the Meta-Analysis of Observational Studies in Epidemiology guidelines. Thirty-four studies (4714 patients) were included in the quantitative analysis. The CSF drainage-related complications were categorised as mild, moderate, and severe. Pooled event rates for each complication category were estimated using a random-effect model. Random-effect uni- and multivariable meta-regression analyses were used to assess the effect of aortic-repair approach (open vs endovascular) and the CSF drainage criteria on CSF drainage-related complications. Results The pooled event rates were 6.5% [95% confidence interval (CI): 4.3–9.8%] for overall complications, 2% (95% CI: 1.1–3.4%) for minor complications, 3.7% (95% CI: 2.5–5.6%) for moderate complications, and 2.5% (95% CI: 1.6–3.8%) for severe complications. The drainage-related-mortality pooled event rate was 0.9% (95% CI: 0.6–1.4%). The uni- and multivariable meta-regression analyses showed no difference in complication rates between the open and endovascular approaches, or between the different CSF drainage protocols. Conclusion The complication rate for CSF drainage is not negligible. Our results help define a more accurate risk–benefit ratio for CSF drain placement at the time of repair of thoracic and thoraco-abdominal aneurysms.
- Published
- 2017
37. T1N0 oesophageal cancer: patterns of care and outcomes over 25 years
- Author
-
Nasser K. Altorki, Mohamed K. Kamel, Sebron Harrison, Andrew B. Nguyen, Mohamed Rahouma, Benjamin Lee, Jeffrey L. Port, and Brendon M. Stiles
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Esophageal Neoplasms ,medicine.medical_treatment ,Kaplan-Meier Estimate ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Epidemiology ,medicine ,Humans ,Aged ,Retrospective Studies ,Cancer Death Rate ,medicine.diagnostic_test ,business.industry ,Hazard ratio ,Cancer ,General Medicine ,Esophageal cancer ,Middle Aged ,medicine.disease ,Endoscopy ,Radiation therapy ,Treatment Outcome ,Esophagectomy ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Surgery ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
OBJECTIVES Historically, surgical resection has been the mainstay of treatment for T1N0 oesophageal cancer (OC). More recently, oesophageal sparing endoscopic techniques have shown value for local control in a large institutional series. However, the effect of their utilization upon survival rates in large population series is largely unknown. METHODS The surveillance, epidemiology, and end results (SEER) database was queried for T1N0M0-OC patients (1988-2013). Patients with multiple treatment types were excluded. Time periods were divided by 5-year increments. Overall survival and cancer-specific survival (CSS) were compared in the group as a whole and in propensity-matched subgroups. Independent predictors of cancer-specific mortality were studied by the Cox proportional hazard models. RESULTS We identified 5497 patients with cT1N0M0 OC. Treatment modalities used were changed significantly over time. The ratio of oesophagectomy when compared with local therapy decreased from 15:1 in 1998-92 to 1.4:1 in 2008-13. The proportion of patients treated with radiation slightly increased (35% vs 41%) between 1988-92 and 2008-13. In the propensity-matched groups, 5-year CSS was similar in patients treated with oesophagectomy and local therapy (81% vs 89%; P = 0.257) (n = 216 in each group), whereas oesophagectomy had superior 5-year CSS compared with radiation alone (73% vs 38%; P
- Published
- 2017
38. Robotic Thymectomy: Learning Curve and Associated Perioperative Outcomes
- Author
-
Nasser K. Altorki, Mohamed K. Kamel, Brendon M. Stiles, Abu Nasar, Jeffrey L. Port, and Mohamed Rahouma
- Subjects
Male ,medicine.medical_specialty ,Thymoma ,Symphysis ,medicine.medical_treatment ,Operative Time ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Robotic Surgical Procedures ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Propensity Score ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Perioperative ,Thymus Neoplasms ,Middle Aged ,medicine.disease ,Thymectomy ,Surgery ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Propensity score matching ,Female ,business ,Learning Curve - Abstract
Recently, robotic-assisted thymectomy (RAT) has emerged as an alternative to either, an open transsternal approach or to a video-assisted thoracoscopic approach, for both thymic tumors and benign lesions. We have reviewed our early experience with RAT to assess the associated learning curve as well as the short-term perioperative outcomes.A prospectively collected database was reviewed for patients who underwent RAT for all causes in the period 2012-2016. Robotic thymectomy cases were stratified and compared according to the number of cases performed by each surgeon (≤15 versus15 cases). A propensity score matching was done to compare perioperative outcomes in patients undergoing robotic and transsternal resection of thymomas.Seventy patients (47 females) with a median age of 52, underwent RAT. The median operative time was 102 min with 5 conversions to an open approach for local invasion (n = 3) or for complete pleural symphysis (n = 2). There were 2 rib fractures and 1 recurrent laryngeal nerve palsy. Median length of chest tube drainage and length of stay were 1 and 3 days, respectively. Operative time and estimated blood loss plateaued after surgeon's initial 15-20 cases, which may reflect the initial learning curve. A comparison between early and late robotic cases showed that with the growing experience, the operative time becomes shorter (94 versus 107 min, P = .018). Propensity score analysis between robotic and transsternal resection of thymoma (n = 22 in each group) showed no significant differences in operative time (P = .79), intraoperative complications (P = .99), or postoperative complications (P = .99).Robotic thymectomy is feasible and safe, and is associated with comparable perioperative outcomes to the traditional transsternal approach in patients undergoing thymomectomy. An initial learning curve of 15-20 robotic thymectomy cases may be required by the surgeons to adequately perform this relatively novel technique.
- Published
- 2017
39. Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison
- Author
-
Benjamin Lee, Mohamed K. Kamel, Abu Nasar, Jeffrey L. Port, Peter J. Kneuertz, Brendon M. Stiles, Nasser K. Altorki, and Mohamed Rahouma
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Thymoma ,medicine.medical_treatment ,Operative Time ,030204 cardiovascular system & hematology ,Risk Assessment ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Robotic Surgical Procedures ,Biopsy ,medicine ,Humans ,Stage (cooking) ,Propensity Score ,Survival rate ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Biopsy, Needle ,Retrospective cohort study ,Perioperative ,Thymus Neoplasms ,Middle Aged ,medicine.disease ,Thymectomy ,Immunohistochemistry ,Sternotomy ,Surgery ,Survival Rate ,Treatment Outcome ,030220 oncology & carcinogenesis ,Feasibility Studies ,Female ,Cardiology and Cardiovascular Medicine ,Complication ,business ,Tomography, X-Ray Computed ,Follow-Up Studies - Abstract
Background Robotic-assisted thymectomy (RAT) is increasingly performed for resection of thymomas. Its application for large tumors remains controversial. In this study, we evaluated the safety and feasibility of RAT for large thymomas in comparison with transsternal thymectomy (ST). Methods A single institution database was reviewed for patients who underwent RAT for thymoma of 4 cm or larger between 2004 and 2016. Propensity scores were applied to match RAT with ST patients, based on age, sex, tumor size, and Masaoka stage. Perioperative outcomes were compared. Results Twenty patients (15 women and 5 men, median age 59 years) underwent RAT for a large thymoma (median size 6.0 cm). A right-sided approach was used in 14 patients (70%). A control group of 34 ST patients (median size 6.7 cm) had similar Masaoka staging ( p = 0.64). Combined resection of adjacent structures, including pericardium, lung, and phrenic nerve, were frequently performed in both groups (50% RAT versus 47% ST, p = 0.83). RAT patients had lower blood loss (25 mL versus 150 mL, p = 0.001), were more frequently managed with a single chest tube (85% versus 56%, p = 0.027), and had a shorter median length of stay (3 days versus 4 days, p = 0.034). There were no perioperative deaths and no major vascular injuries. Three RAT patients (15%) were converted to open approach. Overall complication rates were similar between RAT and ST patients (15% versus 24%, p = 0.45). No difference was seen in R0 resection rates (90% versus 85%, p = 0.62). Conclusions RAT can be performed safely and effectively in a radical fashion for large thymomas. Future studies are necessary to determine long-term oncologic outcomes.
- Published
- 2017
40. Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy
- Author
-
Abu Nasar, Nasser K. Altorki, Jeffrey L. Port, Brendon M. Stiles, and Mohamed K. Kamel
- Subjects
Male ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,VATS lobectomy ,Blood Loss, Surgical ,Antineoplastic Agents ,030204 cardiovascular system & hematology ,Disease-Free Survival ,03 medical and health sciences ,Pneumonectomy ,0302 clinical medicine ,Postoperative Complications ,Carcinoma, Non-Small-Cell Lung ,medicine ,Humans ,Thoracotomy ,Stage (cooking) ,Propensity Score ,Contraindication ,Neoadjuvant therapy ,Aged ,Neoplasm Staging ,Retrospective Studies ,business.industry ,Thoracic Surgery, Video-Assisted ,Induction chemotherapy ,Retrospective cohort study ,Induction Chemotherapy ,Length of Stay ,Middle Aged ,Neoadjuvant Therapy ,Surgery ,030220 oncology & carcinogenesis ,Lymph Node Excision ,Female ,business - Abstract
A video-assisted thoracoscopic surgical (VATS) resection, after induction chemotherapy, has long been considered a relative contraindication. We report our experience with VATS lobectomy after induction chemotherapy for patients with nonsmall cell lung cancer (NSCLC), with propensity-matched group of patients, who underwent an open approach, to determine safety and oncological outcome.A retrospective review of a prospective database (2002-2014) was performed to identify patients undergoing potentially curative lobectomy for NSCLC after induction therapy. Propensity score matching (age, gender, and clinical stage) was performed (1:2) to obtain a balanced cohort of patients undergoing VATS resection and thoracotomy.A total of 285 patients underwent lobectomy after induction therapy, 114 were propensity matched (VATS, n = 40, thoracotomy, n = 74). There were no differences in the clinicopathological factors or type of induction therapy (conventional versus targeted) between VATS and thoracotomy groups. Similarly, no differences were found in the number of lymph nodes resected (12 versus 15, P = .94), the number of stations sampled (4 for each, P = .68), or in the rate of R0 resection (95% versus 96%, P = .81) between VATS and thoracotomy groups. Five VATS cases were converted to an open approach because of adhesions. VATS resection was associated with less estimated blood loss (EBL), shorter length of stay (LOS), and a trend toward fewer postoperative complications. There was no difference in 5 years disease-free survival (DFS) between VATS and thoracotomy groups (73% versus 48%, P = .09). Similarly, for patients who presented with cN2, there were no differences between thoracotomy and VATS groups in DFS (P = .37). On multi-variable analysis (MVA), only the clinical N1/2 status [Hazard ratio (HR): 4.86, P .001] independently predicted poor DFS.A VATS lobectomy is a feasible, safe, and oncologically sound approach after induction therapy for NSCLC. When compared with thoracotomy, VATS lobectomy is associated with lower EBL, shorter LOS, and a trend toward fewer postoperative complications.
- Published
- 2016
41. Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?
- Author
-
Sebron Harrison, Jeffrey L. Port, Brendon M. Stiles, Benjamin Lee, Nasser K. Altorki, Bradley B. Pua, and Mohamed K. Kamel
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,Time Factors ,Databases, Factual ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Risk Assessment ,03 medical and health sciences ,Pneumonectomy ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,Interquartile range ,Humans ,Multicenter Studies as Topic ,Medicine ,Hospital Mortality ,Practice Patterns, Physicians' ,Lung cancer ,Early Detection of Cancer ,Aged ,Randomized Controlled Trials as Topic ,Surgeons ,Thoracic Surgery, Video-Assisted ,business.industry ,Odds ratio ,Middle Aged ,medicine.disease ,United States ,Surgery ,Outcome and Process Assessment, Health Care ,Treatment Outcome ,Thoracotomy ,030228 respiratory system ,Video-assisted thoracoscopic surgery ,Female ,National Lung Screening Trial ,Cardiology and Cardiovascular Medicine ,business ,Complication ,Wedge resection (lung) - Abstract
Introduction Surgical data from the National Lung Screening Trial (NLST) has yet to be closely examined. We sought to analyze surgical procedures and complications from the NLST to determine their relevance to modern surgical practice. Methods The NLST database was queried for patients who underwent surgical resection for confirmed lung cancer, specifically evaluating postoperative complications. Numerical variables were compared using the Mann–Whitney U test. Categorical variables were compared using the χ2 test. Logistic regression uni- and multivariable analysis of independent risk factors of postoperative complications was performed. Results At operation, 80% of patients (n = 821) had lobectomy, 4.1% (n = 42) had pneumonectomy, and 16.1% (n = 166) had sublobar resection, among whom 69% (n = 114) had wedge resection. Only 29.6% (n = 305) of the cohort had a thoracoscopic resection. Although the overall rate of surgical patients with any complication was 31% (n = 318), only 15.5% of patients (n = 160) had major complications, most commonly prolonged air leaks (n = 67, 6.5%). Respiratory failure (n = 28, 2.7%), prolonged ventilation (n = 9, 0.9%), myocardial infarction or cardiac arrest (n = 7, 0.7%), and stroke (n = 2, 0.2%) were rare events. Overall 30-day mortality in patients undergoing resection was 1.7% (n = 18). On multivariable analysis, greater smoking pack history (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.001-1.01) and pulmonary comorbidities (OR, 1.34; 95% CI, 0.98-1.82) were significant or approached significance for an association with complications/death, whereas sublobar resection (OR, 0.59; 95% CI, 0.38-0.94) and video-assisted thoracoscopic surgery approach (OR, 0.76; 95% CI, 0.56-1.04) were significant or approached significance for an association with decreased rates of complications/death. Conclusions Operative mortality and postoperative morbidity were very low in patients undergoing resection for screen-detected lung cancer. Increased use of sublobar resection and minimally invasive surgical approaches may be associated with fewer complications.
- Published
- 2019
42. Endoscopic radial artery harvesting for coronary artery bypass grafting
- Author
-
Yongle Ruan, Mohamed Hossny, Mohamed K. Kamel, Faiza M. Khan, Irbaz Hameed, Leonard N. Girardi, Kritika Mehta, Massimo Baudo, Ajita Naik, Mohamed Rahouma, Cristiano Spadaccio, Matthew Wingo, Mario Gaudino, and Ahmed Abouarab
- Subjects
medicine.medical_specialty ,medicine.anatomical_structure ,Bypass grafting ,business.industry ,medicine.artery ,medicine ,Wound complication ,Radial artery ,business ,Artery ,Surgery - Published
- 2018
43. Surgery is the Optimum Local Therapeutic Modality for Second Primary Lung Cancer
- Author
-
Jeffrey L. Port, Nasser K. Altorki, and Mohamed K. Kamel
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,Disease ,030204 cardiovascular system & hematology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Epidemiology ,medicine ,Humans ,030212 general & internal medicine ,Stage (cooking) ,Lung cancer ,business.industry ,Neoplasms, Second Primary ,General Medicine ,medicine.disease ,Combined Modality Therapy ,Surgery ,Radiation therapy ,Cohort ,Neoplasm Recurrence, Local ,Cardiology and Cardiovascular Medicine ,business ,Lung cancer screening - Abstract
Recent advances in lung cancer screening have encouraged many clinicians to apply computed tomography screening principles to their resected patients. These patients represent a high-risk cohort for the development of either recurrent disease or a metachronous second lung primary. 1,2 Often with current imaging, cytology, and genetic analysis the distinction can be challenging and the surgeon would offer definitive local therapy for patients who clinically present with local disease. The exact incidence of second primaries and which local therapy is superior is not well understood. Taioli et al. 3 performed an analysis of the Surveillance, Epidemiology, and End Results database for patients with second primary lung cancers discovered 6 months or more after potentially curative resection of stage-one disease. Despite the non-randomized nature and the dearth of information on how treatment was assigned, the study highlights several important points. Overall, 5.4% of patients who undergo curative resection for stage I disease would develop a second cancer, the most of which are apparent before 3 years. This represents a significant risk and supports close monitoring of our resected patients. In addition, only 58.5% of these second primaries were stage I. The improvements in radiation therapy, particularly stereotactic body radiation therapy (SBRT), have encouraged radiation oncologists to offer definitive radiation to early-stage lung cancer patients who are deemed medically inoperable. SBRT has achieved good local control for this high-risk group and has encouraged some to question whether it should be offered to the medically operable as well. Unfortunately, 2 randomized trials comparing SBRT to lobectomy, closed due to the slow accrual. 4 So, what should be the optimum therapy offered for second lung primaries? Perhaps, the best therapy is the same as for first primaries. We performed a retrospective, propensity-matched
- Published
- 2016
44. Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non-Small Cell Lung Cancer
- Author
-
J. Port, Navneet Narula, Abu Nasar, Nasser K. Altorki, Galal Ghaly, Mohamed Rahouma, Brendon M. Stiles, Mohamed K. Kamel, and Paul C. Lee
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Lung Neoplasms ,Urology ,Standardized uptake value ,030204 cardiovascular system & hematology ,Mastectomy, Segmental ,03 medical and health sciences ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Survival rate ,Aged ,Retrospective Studies ,Aged, 80 and over ,Univariate analysis ,business.industry ,Proportional hazards model ,Hazard ratio ,Confidence interval ,Surgery ,Survival Rate ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Female ,business ,Wedge resection (lung) - Abstract
Objectives Sublobar resection is advocated for patients with NSCLC and compromised cardiopulmonary reserve, and for selected patients with early stage disease. Anatomic segmentectomy (AS) has traditionally been considered superior to wedge resection (WR), but well-balanced comparative studies are lacking. We hypothesize that WR and AS are associated with comparable oncologic outcomes for patients with cT1N0 NSCLC. Methods A retrospective review of a prospective database was performed (2000–2014) for cT1N0 patients, excluding patients with multiple primary tumors, carcinoid tumors, adenocarcinoma in situ, and minimally invasive adenocarcinoma. Demographic, clinical, and pathological data were reviewed. Overall survival (OS) and disease-free survival (DFS) were estimated using the Kaplan-Meier method and differences compared using log-rank test. Multivariable analysis (MVA) of factors affecting DFS was performed by Cox regression analysis. For further comparison of the effect of resection type on survival, propensity score matching (i.e., by age, sex, Charlson comorbidity index, percent forced expiratory volume in 1 second (FEV 1 %), clinical tumor size, and tumor maximum standardized uptake value) was performed to obtain balanced cohorts of patients undergoing WR and AS (n = 76 per group). Results Two hundred eighty-nine patients met our selection criteria, including WR in 160 and AS in 129. Poor performance status and limited cardiopulmonary reserve were the primary indications for sublobar resection in 76% of WR patients and in 62% of AS patients ( p = 0.011). Thirteen patients (4.5%) had pN1/2 disease. Patients undergoing AS were more likely to have nodal sampling/dissection [123 (95%) versus 112 (70%); p p p = 0.001). However, there was no difference between patients undergoing WR versus AS in local recurrence [15 versus 14; p = 0.68] or 5-year DFS (51% versus 53%; p = 0.7; median follow-up 34 months). Univariate analysis showed no effect of extent of resection on DFS [hazard ratio 1.07 (95% confidence interval 0.74–1.56); p = 0.696]. MVA showed that only tumor maximum standardized uptake value was associated with worse DFS [hazard ratio 1.07 (95% confidence interval 1.01–1.13); p = 0.016]. In the propensity-matched analysis of balanced subgroups, there was also no difference ( p = 0.950) in 3- or 5-year DFS in cT1N0 patients undergoing WR (65% and 49%) or AS (68% and 49%). Conclusions Our data show that WR and AS are comparable oncologic procedures for carefully staged cT1N0 NSCLC patients. Although AS is associated with a more thorough lymph node dissection, this did not translate to a survival benefit in this patient population with a low rate of nodal metastases.
- Published
- 2016
45. Predictors of Pleural Implants in Patients With Thymic Tumors
- Author
-
Mohamed Rahouma, Brendon M. Stiles, Galal Ghaly, Jeffrey L. Port, Nasser K. Altorki, Mohamed K. Kamel, Paul C. Lee, and Abu Nasar
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Pleural Neoplasms ,New York ,030204 cardiovascular system & hematology ,Disease-Free Survival ,03 medical and health sciences ,Pleural disease ,0302 clinical medicine ,Interquartile range ,Risk Factors ,Biopsy ,medicine ,Humans ,Neoplasm Invasiveness ,Pleural Neoplasm ,Survival rate ,Aged ,Neoplasm Staging ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Proportional hazards model ,Hazard ratio ,Biopsy, Needle ,Retrospective cohort study ,Thymus Neoplasms ,Middle Aged ,medicine.disease ,Prognosis ,Thymectomy ,Surgery ,Tumor Burden ,Survival Rate ,030220 oncology & carcinogenesis ,Pleura ,Female ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies ,Forecasting - Abstract
In patients with thymic neoplasms, the pleural space is a frequent site of either synchronous or metachronous tumor dissemination after surgical resection. The objective of this study was to identify factors that predict pleural dissemination, which would allow for better surgical planning and consideration of novel adjuvant or surveillance strategies.A retrospective review of a prospective database (2000 to 2014) was performed to identify patients with thymic tumors (excluding neuroendocrine). Demographic, clinical, and pathologic data were reviewed. Multivariable Cox regression analysis was performed to determine independent predictors of pleural implants (either occult synchronous or metachronous). Univariate predictors (p0.20) were selected for inclusion in a multivariable model. Receiver operating characteristic (ROC) curve was used to assess the effect and cutoff value of tumor size on the incidence of pleural metastasis.One hundred sixty-two patients with thymic tumors were identified. Pleural deposits were incidentally identified intraoperatively in 4 patients (2.5%) and developed during follow-up in 15 patients (10%), with a median follow-up of 34 months (interquartile range, 12 to 71). Univariate predictors of pleural metastasis were macroscopic capsular/organ invasion, preoperative core/surgical biopsy, induction therapy, pathologic tumor size, and World Health Organization type B3/C. In the multivariable model, core/surgical biopsy (hazard ratio [HR] 9.45, p = 0.002), macroscopic capsular invasion (HR 10.18, p = 0.008), and larger tumor size (HR 1.34, p = 0.044) were found to be independent predictors of pleural metastasis. The relation between the pathologic tumor size and development of pleural metastasis was further investigated with the ROC curve (area under the curve 0.78, p0.001), and the cutoff tumor size that gave the best combined sensitivity and specificity was 6.5 cm. Overall survival of patients with pleural implants was 88% and 50% at 5 and 10 years, respectively. Five- and 10- year disease-free survival for the whole cohort was 80% and 30%, respectively.Development of pleural metastasis is predictable. Pathologic tumor size, an independent predictor of pleural implants, can be assessed intraoperatively. Because preoperative core needle biopsy is also an independent predictor of pleural dissemination, its use and execution should be carefully considered. Pleural exploration at the index operation should be considered in high-risk patients. Further studies are needed to confirm these findings and to assess the role of novel therapeutic strategies in reducing pleural disease.
- Published
- 2016
46. PUB005 Robotic Thymectomy: Comparable Perioperative Outcomes for Benign Lesions and Early Stage Thymic Tumors
- Author
-
Jeffrey L. Port, Galal Ghaly, Nasser K. Altorki, Mohamed K. Kamel, Brendon M. Stiles, and Abu Nasar
- Subjects
Pulmonary and Respiratory Medicine ,Thymectomy ,medicine.medical_specialty ,Oncology ,business.industry ,medicine.medical_treatment ,medicine ,Thymic Tumors ,Perioperative ,Stage (cooking) ,business ,Surgery - Published
- 2017
47. PUB002 Predictors of Incomplete Resection in Patients Undergoing Esophagectomy for Cancer: Induction Chemotherapy Does Not Increase R0 Resection Rate
- Author
-
Brendon M. Stiles, Paul C. Lee, Abu Nasar, Mohamed K. Kamel, Weston Andrews, Jeffrey L. Port, and Nasser K. Altorki
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Chemotherapy ,business.industry ,medicine.medical_treatment ,Incomplete Resection ,Surgery ,Oncology ,Esophagectomy ,medicine ,In patient ,Cancer Induction ,business ,R0 resection - Published
- 2017
48. PUB008 1,000 Video-Assisted Thoracoscopic Lobectomies (VATS): A Single Institution's Experience
- Author
-
Mohamed K. Kamel, Brendon M. Stiles, Jefferey Port, Sebron Harrison, Mohamed Rahouma, Nasser K. Altorki, and Galal Ghaly
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Oncology ,business.industry ,General surgery ,Medicine ,Video assisted ,Single institution ,business - Published
- 2017
49. PUB009 New Chemotherapy Regimen; Does It Really Work for Esophageal Cancer Adenocarcinoma?
- Author
-
Paul C. Lee, Mohamed Rahouma, Mohamed K. Kamel, Barry Kaplan, and Galal Ghaly
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Work (electrical) ,business.industry ,Internal medicine ,Medicine ,Adenocarcinoma ,Esophageal cancer ,business ,medicine.disease ,Chemotherapy regimen - Published
- 2017
50. PUB003 Predictors of Mortality, Morbidity and Prolonged Length of Stay after Lobectomy: A Population Based Analysis
- Author
-
Mohamed K. Kamel, Abu Nasar, Nasser K. Altorki, Andrew B. Nguyen, Subroto Paul, Brendon M. Stiles, Jeffrey L. Port, and Paul C. Lee
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Oncology ,business.industry ,Emergency medicine ,medicine ,Population based ,business - Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.